Identification of novel metabolites of pioglitazone in rat and dog

Authors:
  • JRJ. R. Reed
    J. R. Reed
  • MCM. Creighton
    M. Creighton
  • DLD. Q. Liu
    D. Q. Liu
  • YTY. S. Tang
    Y. S. Tang
  • DHD. F. Hora
    D. F. Hora
  • WFW. Feeney
    W. Feeney
  • JSJ. Szewczyk
    J. Szewczyk
  • RBR. Bakhtiar
    R. Bakhtiar
  • SVS. H. Vincent
    S. H. Vincent

Abstract
1. Four new metabolites of pioglitazone were identified by liquid chromatography-mass spectrometry (LC-MS/MS) as being formed by hydroxylation (M-VII and M-VIII), opening of the thiazolidinedione ring (M-X) and by desaturation of the terminal ethyl side chain or tether ethoxy moiety (M-IX), respectively. The structure of one of the hydroxylated metabolites (M-VII) was confirmed by chemical modification using the Jones reaction. 2. Oxidative cleavage of the thiazolidinedione ring is a novel pathway not previously reported for pioglitazone. 3. The hydroxylated M-VII was detected in incubations with rat, dog and human liver and kidney microsomes, and in plasma from rats and dogs dosed orally with [(3)H]pioglitazone. 4. The carboxylic acid derivative of M-VII (M-V) and its taurine conjugate were the major radioactive components in dog bile.

This publication has 11 references indexed in Scilit: